Miramar, FL, United States of America

Catherine Spanoudis

This inventor holds 1 USPTO granted patent. Top assignee: Immunitybio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Spanoudis. Retrieved from https://idiyas.com/inventor/catherine-spanoudis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Catherine Spanoudis

Introduction

Catherine Spanoudis is a notable inventor based in Miramar, FL (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Catherine holds a patent for "ANTI-CD26 PROTEINS AND USES THEREOF." This innovative patent reflects her expertise in creating proteins that target specific biological pathways, which can be crucial in treating various diseases.

Career Highlights

Catherine is currently associated with ImmunityBio, Inc., where she applies her knowledge and skills to further research and development in immunotherapy. Her role at the company allows her to collaborate with other experts in the field, driving forward the mission of enhancing immune responses against cancer and other diseases.

Conclusion

Catherine Spanoudis exemplifies the spirit of innovation in biotechnology through her patent and work at ImmunityBio, Inc. Her contributions are paving the way for new therapeutic approaches that could significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…